Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 31, Issue 4, 2017, Pages 1381-1384

  Boettcher, Brent T ^a   Woehlck, Harvey J ^a   Reck, Sarah E ^a   Hong, Johnny C ^a   Zimmerman, Michael A ^a   Kim, Joohyun ^a   Zundel, M Tracy ^a   Freed, Julie K ^a   Pagel, Paul S ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

hydroxocobalamin; liver transplantation; norepinephrine; vasoplegic syndrome; vasopressin

Indexed keywords

EPINEPHRINE; HYDROXOCOBALAMIN; METHYLENE BLUE; NORADRENALIN; VASOPRESSIN; VITAMIN B COMPLEX;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; ASCITES; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; GENERAL CONDITION DETERIORATION; HEART OUTPUT; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; HYPOTENSION; KIDNEY INJURY; LIVER FUNCTION; LIVER INJURY; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MODEL FOR END STAGE LIVER DISEASE SCORE; MOTOR VEHICLE; PARACENTESIS; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; RIB FRACTURE; SOMNOLENCE; THERMODILUTION; TRAFFIC ACCIDENT; TRANSVERSE PROCESS; VASOPLEGIA; DIAGNOSTIC IMAGING; INTRAVENOUS DRUG ADMINISTRATION; PEROPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADULT; AGED; HUMANS; HYDROXOCOBALAMIN; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE COMPLICATIONS; LIVER TRANSPLANTATION; MALE; TREATMENT OUTCOME; VASOPLEGIA; VITAMIN B COMPLEX;

EID: 85008219279     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.10.011     Document Type: Article

References (28)

1. Riha, H., Augoustides, J.G., Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery. J Cardiothorac Vasc Anesth 25 (2011), 736–738.
2. Kalambokis, G., Economou, M., Fotopoulos, A., et al. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig Dis Sci 50 (2005), 1771–1777.
3. Wagener, G., Kovalevskaya, G., Minhaz, M., et al. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth 25 (2011), 665–670.
4. Beasley, D., McGuiggin, M., Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J Exp Med 179 (1994), 71–80.
5. Hosseinian, L., Weiner, M., Levin, M.A., et al. Methylene blue: Magic bullet for vasoplegia?. Anesth Analg 122 (2016), 194–201.
6. Vutskits, L., Briner, A., Klauser, P., et al. Adverse effects of methylene blue on the central nervous system. Anesthesiology 108 (2008), 684–692.
7. Roderique, J.D., VanDyck, K., Holman, B., et al. The use of high-dose hydroxocobalamin for vasoplegic syndrome. Ann Thorac Surg 97 (2014), 1785–1786.
8. Burnes ML, Boetthcer BT, Woehlck HJ, et al: Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass. J Cardiothorac Vasc Anesth [In Press].
9. Cyanokit [package insert]. Columbia, MD: Meridian Medical Technologies, Inc, 2006.
10. Mannaioni, G., Vannacci, A., Marzocca, C., et al. Acute cyanide intoxication treated with a combination of hydroxycobalamin, sodium nitrite, and sodium thiosulfate. J Toxicol Clin Toxicol 40 (2002), 181–183.
11. Forsyth, J.C., Mueller, P.D., Becker, C.E., et al. Hydroxocobalamin as a cyanide antidote: Safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 31 (1993), 277–294.
12. Gerth, K., Ehring, T., Braendle, M., et al. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol (Phila) 44:Suppl 1 (2006), 29–36.
13. Moccia, F., Bertoni, G., Pla, A.F., et al. Hydrogen sulfide regulates intracellular Ca2+concentration in endothelial cells from excised rat aorta. Curr Pharm Biotechnol 12 (2011), 1416–1426.
14. Fujita, Y., Fujino, Y., Onodera, M., et al. A fatal case of acute hydrogen sulfide poisoning caused by hydrogen sulfide: hydroxocobalamin therapy for acute hydrogen sulfide poisoning. J Anal Toxicol 35 (2011), 119–123.
15. Haouzi, P., Chenuel, B., Sonobe, T., High-dose hydroxocobalamin administered after H2S exposure counteracts sulfide-poisoning-induced cardiac depression in sheep. Clin Toxicol (Phila) 53 (2015), 28–36.
16. Truong, D.H., Mihajlovic, A., Gunness, P., et al. Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)). Toxicology 242 (2007), 16–22.
17. Ebrahimkhani, M.R., Mani, A.R., Moore, K., Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: A hypothesis. Gut 54 (2005), 1668–1671.
18. Rajanayagam, M.A., Li, C.G., Rand, M.J., Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 108 (1993), 3–5.
19. Greenberg, S.S., Xie, J., Zatarain, J.M., et al. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 273 (1995), 257–265.
20. Li, C.G., Rand, M.J., Effects of hydroxocobalamin and haemoglobin on no-mediated relaxations in the rat anococcygeus muscle. Clin Exp Pharmacol Physiol 20 (1993), 633–640.
21. Sampaio, A.L., Dalli, J., Brancaleone, V., et al. Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: Downstream regulation of COX-2, IL-1beta, TNF-alpha, IL-6, and HMGB1 expression. Mediators Inflamm, 2013, 2013, 741804.
22. Uhl, W., Nolting, A., Golor, G., et al. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila) 44:Suppl 1 (2006), 17–28.
23. Gehrie, E., Booth, G., Transfusion medicine illustrated: An unusual cause of red plasma. Transfusion, 54, 2014, 11.
24. Curry, S.C., Connor, D.A., Raschke, R.A., Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 24 (1994), 65–67.
25. Lawrence, D.T., Kirk, M.A., Chemical terrorism attacks: Update on antidotes. abstract xi Emerg Med Clin North Am 25 (2007), 567–595.
26. Fortin, J.L., Ruttimann, M., Capellier, G., et al. Successful organ transplantation after treatment of fatal cyanide poisoning with hydroxocobalamin. Clin Toxicol (Phila) 45 (2007), 468–471.
27. Fischer, G.W., Levin, M.A., Vasoplegia during cardiac surgery: Current concepts and management. Semin Thorac Cardiovasc Surg 22 (2010), 140–144.
28. Gomes, W.J., Carvalho, A.C., Palma, J.H., et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino) 39 (1998), 619–623.